看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 0.5x - 0.5x | 0.5x |
| Selected Fwd Ps Multiple | 0.4x - 0.5x | 0.5x |
| Fair Value | ₩17,061 - ₩18,856 | ₩17,959 |
| Upside | 44.8% - 60.1% | 52.4% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Dongwha Pharm.Co.,Ltd | - | KOSE:A000020 |
| JW Lifescience Corporation | - | KOSE:A234080 |
| Kyung Dong Pharmaceutical Co., Ltd. | - | KOSDAQ:A011040 |
| Dong-A ST Co., Ltd. | - | KOSE:A170900 |
| BCWORLD PHARM. Co., Ltd. | - | KOSDAQ:A200780 |
| HANDOK Inc. | - | KOSE:A002390 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| A000020 | A234080 | A011040 | A170900 | A200780 | A002390 | |||
| KOSE:A000020 | KOSE:A234080 | KOSDAQ:A011040 | KOSE:A170900 | KOSDAQ:A200780 | KOSE:A002390 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 8.6% | 5.5% | 1.9% | 2.7% | 7.8% | 1.4% | ||
| 3Y CAGR | 16.6% | 9.4% | 3.0% | 5.6% | 6.4% | -0.7% | ||
| Latest Twelve Months | 28.7% | 7.5% | 19.2% | 5.1% | -0.4% | -2.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 6.8% | 10.4% | 3.3% | 1.9% | -3.2% | 0.4% | ||
| Prior Fiscal Year | 7.6% | 13.6% | -12.7% | 1.7% | 3.5% | -5.5% | ||
| Latest Fiscal Year | 1.2% | 19.8% | 2.8% | -0.2% | -5.9% | -10.4% | ||
| Latest Twelve Months | 1.2% | 19.8% | 2.8% | -0.2% | -5.9% | -10.4% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 5.8x | 4.7x | 11.8x | 140.1x | 13.4x | 18.2x | ||
| Price / LTM Sales | 0.4x | 0.8x | 0.8x | 0.6x | 0.6x | 0.3x | ||
| LTM P/E Ratio | 31.2x | 4.2x | 28.6x | -350.9x | -10.2x | -3.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.4x | 0.6x | 0.8x | |||||
| Historical LTM P/S Ratio | 0.3x | 0.4x | 0.9x | |||||
| Selected Price / Sales Multiple | 0.5x | 0.5x | 0.5x | |||||
| (x) LTM Sales | 507,358 | 507,358 | 507,358 | |||||
| (=) Equity Value | 244,869 | 257,757 | 270,645 | |||||
| (/) Shares Outstanding | 13.8 | 13.8 | 13.8 | |||||
| Implied Value Range | 17,791.15 | 18,727.53 | 19,663.91 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 17,791.15 | 18,727.53 | 19,663.91 | 11,780.00 | ||||
| Upside / (Downside) | 51.0% | 59.0% | 66.9% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A000020 | A234080 | A011040 | A170900 | A200780 | A002390 | |
| Value of Common Equity | 172,406 | 185,040 | 155,993 | 430,493 | 45,261 | 162,134 | |
| (/) Shares Outstanding | 27.7 | 15.5 | 26.9 | 9.2 | 9.2 | 13.8 | |
| Implied Stock Price | 6,220.00 | 11,950.00 | 5,790.00 | 47,000.00 | 4,900.00 | 11,780.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 6,220.00 | 11,950.00 | 5,790.00 | 47,000.00 | 4,900.00 | 11,780.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |